Serevent, BroPair Spiromax, Seffalair Spiromax (salmeterol) is a small molecule pharmaceutical. Salmeterol was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against beta-2 adrenergic receptor.
|Trade Name||BroPair Spiromax, Seffalair Spiromax|
|Indication||asthma, bronchial spasm|
|Drug Class||Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives)|